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Abstract
Background: Retinal pigment epithelium cells play an important role in the pathogenesis of age
related macular degeneration. Their morphological, molecular and functional phenotype changes in
response to various stresses. Functional profiling of genes can provide useful information about the
physiological state of cells and how this state changes in response to disease or treatment. In this
study, we have constructed a functional profile of the genes expressed by the ARPE-19 cell line of
retinal pigment epithelium.
Methods: Using Affymetrix MAS 5.0 microarray analysis, genes expressed by ARPE-19 cells were
identified. Using GeneChip® annotations, these genes were classified according to their known
functions to generate a functional gene expression profile.
Results: We have determined that of approximately 19,044 unique gene sequences represented
on the HG-U133A GeneChip® , 6,438 were expressed in ARPE-19 cells irrespective of the
substrate on which they were grown (plastic, fibronectin, collagen, or Matrigel). Rather than focus
our subsequent analysis on the identity or level of expression of each individual gene in this large
data set, we examined the number of genes expressed within 130 functional categories. These
categories were selected from a library of HG-U133A GeneChip® annotations linked to the
Affymetrix MAS 5.0 data sets. Using this functional classification scheme, we were able to
categorize about 70% of the expressed genes and condense the original data set of over 6,000 data
points into a format with 130 data points. The resulting ARPE-19 Functional Gene Expression
Profile is displayed as a percentage of ARPE-19-expressed genes.
Conclusion: The Profile can readily be compared with equivalent microarray data from other
appropriate samples in order to highlight cell-specific attributes or treatment-induced changes in
gene expression. The usefulness of these analyses is based on the assumption that the numbers of
genes expressed within a functional category provide an indicator of the overall level of activity
within that particular functional pathway.
Background
The retinal pigment epithelium (RPE) is a monolayer of
hexagonal cells separating the neural retina from the
underlying choroidal vascular bed. RPE cells are essential
for development, survival, and physiological activity of
photoreceptor cells [1,2]. RPE cells provide the molecular
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somerized visual pigment back to the active isomer for
subsequent formation of rhodopsin [3]. RPE phagocytizes
spent photoreceptor outer segments; provides nutrients
to, and removes metabolic waste from, the photorecep-
tors; contributes to retinal adhesion and maintenance of
the blood-retinal barrier; and absorbs light and dissipates
heat energy derived from incident light [4,5]. Recent evi-
dence shows that RPE cells also participate in the immu-
nologic functions in the retina. RPE cells can express
major histocompatibility complex (MHC) class I and II
antigens and the intercellular adhesion molecule-1
(ICAM-1). These cells process and present the antigen to
helper T cells [6-9]. RPE responds to proinflammatory
cytokines and secretes IL-6, IL-8, and monocyte chemotac-
tic protein [10-14]. Through these mechanisms RPE cells
play a key role in inflammatory, infectious, and degenera-
tive diseases of the retina. Impairment of RPE functions
have been implicated in a number of hereditary retinal
degenerations [15-18], and more importantly in the
pathogenesis of age-related macular degeneration (AMD),
one of the most prevalent causes of visual impairment in
elderly [19]. Given the importance of RPE cells in the nor-
mal physiology and disease of retina, RPE has become the
subject of intense investigation especially those elucidat-
ing the role of RPE cells in the molecular mechanisms of
AMD. Transplantation of normal as well as genetically
modified RPE cells is being envisaged as a possible treat-
ment of retinal degenerations [20,21]. Given the pivotal
role of RPE in retinal development, physiology and dis-
eases it is important to investigate the gene expression
profile of these cells, which will than lay the foundation
for further molecular characterization of RPE cells in both
normal and diseased states.
DNA microarray technology provides a view of the expres-
sion profiles of a cell sample that encompasses virtually
the entire genome. Microarray technology has a number
of distinct applications including DNA sequencing, muta-
tion analysis, gene discovery, and gene expression analysis
[22-26]. Microarray technology allows a rapid quantita-
tive measurement of gene expression within a tissue sam-
ple, as defined by messenger RNA (mRNA) abundance.
The opportunity to quantitate gene expression on a
genome-wide scale has added a new dimension to our
understanding of many biologic and disease processes.
However, analysis of large data sets derived from microar-
ray analysis can be problematic. It is an overwhelming
task to consider the expression levels of each of the twenty
or so thousand known genes individually. An alternative
strategy is to group individual genes into functional cate-
gories in order to generate what has been termed a "func-
tional gene profile". Different types of analyses can then
be applied to gene profiles. For example, functional cate-
gories of genes displaying the highest levels of expression
can be identified and thus provide a means for focusing
on groups of functionally related genes that may be highly
expressed by a specific cell type or physiological state.
"Cluster analysis" is another more complex type of gene
profile analysis in which significant changes in gene
expression due to some experimental variable are mapped
with respect to functional categories.
We propose a novel approach to gene profile analysis
based on simply the total number of genes within a func-
tional category that are expressed above some pre-deter-
mined level. In order to meet the goal of generating a data
set that will be comprehensive but not too large to be
readily useful, we have generated a functionally classified
list of genes whose expression level met the specific crite-
ria established by Affymetrix analysis instead of consider-
ing the absolute level of expression. Below we describe
130 functional categories that account for 68% of the
genes represented on the Affymetrix microarray chip, and
70% of the genes expressed by the ARPE-19 cell line. Key
words for the functional categories were chosen from the
HG-U133A GeneChip® Library, allowing us to use Affyme-
trix annotation terms (i.e., key words) to sort genes into
categories. We used this classification scheme to calculate
the number of functionally related genes expressed within
a category and to produce a ARPE-19 Gene Expression
Profile. Since data for each category consists of a single
number, the entire database for RPE gene expression can
be represented in a Profile with 130 data points. We sug-
gest that comparing the ARPE-19 Profile with the profile
of genes represented on the Affymetrix HG-U133A Gene-
Chip® may provide a measure of the cell-specific pattern of
gene expression unique for RPE cells. A RPE-specific
expression profile data base would have a number of
potential uses, such as selecting specific genes and func-
tionally related groups of genes for further analysis with
microarray and validation by RT-PCR. Data already avail-
able in the literature demonstrates that many of the genes
included in our expression profile are known to be
present in ARPE-19 cells as validated by quantitative RT-
PCR (for example, see Chowers I 2004 IOVS [27]). We fur-
ther suggest that functional categories with large numbers
of expressed genes may reflect high relative importance of
those specific functions to RPE. Another unique aspect of
our approach was that it excluded from analysis any genes
whose expression was dependent on the substrate upon
which the ARPE-19 cells were grown. There is no uni-
formly accepted substrate utilized researchers in this field,
yet expression of certain classes of genes is known to be
substrate dependent. (See Discussion.) We grew cells on
four commonly used substrates (fibronectin, Matrigel,
collagen, and uncoated plastic culture dishes) and
included in our analysis only those genes that were uni-
formly expressed by cells on all four substrates. Our intent
was to focus on "substrate-independent" genes that wouldPage 2 of 10
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tions. The advantages and disadvantages related to this




ARPE-19 cells were used in the experiments. These are dip-
loid non-transformed human RPE cells that display many
properties typical of differentiated RPE in vivo [28]. ARPE-
19 cells were obtained from a commercial source (ATCC,
Manassas, VA). The cells were plated on 75-cm2 flasks at a
density of 10,000 cells/cm2 and maintained in culture
until the plates became >95% confluent. Cultures were
fed three times a week with Dulbecco's modified Eagle's
medium-nutrient mixture F-12 (DMEM-F-12; GIBCO,
Invitrogen Corporation, Grand Island, NY) supplemented
with 10% fetal bovine serum, 100 U/mL penicillin, and
100 µg/mL streptomycin. Cultures were passaged by dis-
sociation in 0.05% (wt/vol) trypsin. For the microarray
experiments, cells belonging to passage 4 were used 24
hrs. after removing serum from the medium in order to
further synchronize the metabolic and physiological state
of cells.
Substrate-dependent genes
Our overall goal in these experiments was to generate a
functional catalogue of "core" ARPE-19 genes. To achieve
that goal, we sought to avoid genes that might be highly
sensitive to exact culturing conditions, such as the choice
of substrate. While substrate-sensitive genes are likely to
be very important to the cell, as a group they may con-
found our results. Since there is no uniformly accepted
substrate for APRE-19 culture, we reasoned that a cata-
logue of genes that were expressed regardless of substrate
would provide the best standard. Cells were grown on
four commonly used substrates: fibronectin, Matrigel, col-
lagen, and uncoated plastic. Each sample was run on a
separate chip and analyzed as described below. Any genes
not expressed on all four substrates were identified as
"substrate-specific genes" and were removed from further
analysis. Data from the remaining substrate-independent
genes were considered as n = 4 (In other words, since we
only included genes uniformly expression in all four sam-
ples, there is no variation in the gene expression profile
among the n = 4). Variability in expression levels of sub-
strate-independent genes among these four chips was rel-
atively low (see Results) suggesting that overall variability
due to technical factors was low.
Microarray methods
The RNA isolation procedures for the Affymetrix analysis
were conducted using TRIzol Reagent (GIBCO, Carlsbad,
CA) according to the manufacturer's instructions. Ini-
tially, the quality of total RNA was assessed by electro-
phoresis through a 1% agarose gel, then the Agilent
Bioanalyzer System (Agilent Technologies, Palo Alto, CA)
immediately prior to cRNA synthesis. The procedures for
the Affymetrix gene chips, beginning with first strand
cDNA synthesis, were conducted by Genome Explorations
(Memphis, Tennessee). The Human Genome U133A
GeneChip® contains 22,283 probe sets together with
expressed sequence tag (EST) sequences. The RNA (iso-
lated using TRIzol) was run over of a G50 spin column.
First and second strand cDNA were synthesized from 15
µg of total RNA using the SuperScript Double-Stranded
cDNA Synthesis Kit (GIBCO, Carlsbad, CA) and oligo-
dT24-T7 (5'-GGC CAG TGA ATT GTA ATA CGA CTC ACT
ATA GGG AGG CGG-3') primer according to the manu-
facturer's instructions. cRNA was synthesized and labeled
with biotinylated UTP and CTP by in vitro transcription
using the T7 promoter coupled double stranded cDNA as
template and the T7 RNA Transcript Labeling Kit (ENZO
Diagnostics Inc. Farmingdale NY). The fragmented cRNA
was hybridized to the olygonucleotide array, washed,
stained with phycoerythrein conjugated streptavidin
(Molecular Probes, Eugene OR), and scanned. Intensities
were determined using a laser confocal scanner (Hewlett-
Packard; Palo Alto, CA).
The scanned images were analyzed using Microarray Suite
Version 5.0 (MAS 5.0, Affymetrix, Inc., Santa Clara, CA).
The MAS 5.0 statistical algorithms calculate signal inten-
sity, probe set detection, probe set (gene expression)
change, and signal log ratio. The signal intensity for each
gene was calculated as the average intensity difference,
represented by [S(PM – MM)/(number of probe pairs)],
where PM and MM denote perfect-match and mismatch
probes.
The analysis applied a decision matrix based on the
hybridization behavior of all 11 probe pairs per probe set.
These matrices are used to determine if the gene is
expressed above a threshold level (i.e., called Present by
Absolute Call decision matrix). Investigators can change
the specificity and sensitivity criteria for the present call by
changing the alpha-1 value in the MAS 5.0 software. We
used a value of 0.05 as a standard and 0.07 or 0.18 for less
restrictive present calls.
Many genes on the chip are represented by more than one
probe set. Since we were interested in the number of
expressed genes, not the number of probe sets, a method
was devised for selecting a single probe set to represent
each gene. First, we performed a search for multiple probe
sets using the designated Unigene ID or title for each gene.
Once the redundant probe sets were identified, we deter-
mined the coefficient of variation of the expression levels
of each probe set for the n of 4 chips. The probe set with
the lowest coefficient of variation was chosen. Data fromPage 3 of 10
(page number not for citation purposes)
BMC Ophthalmology 2005, 5:25 http://www.biomedcentral.com/1471-2415/5/25
Page 4 of 10
(page number not for citation purposes)
Functional categories of genes represented on the HG-U133A GeneChip174 and expressed by ARPE-19 cellsigure 1
Functional categories of genes represented on the HG-U133A GeneChip174 and expressed by ARPE-19 cells. A 
total 130 functional categories are displayed on the abscissa. These are arranged alphabetically in groups under 15 large func-
tional subheadings indicated on the right and separated by dashed lines. The numbers of genes represented and expressed 
were converted into percentages indicated on the ordinate. The formulae used for calculating percentages were different for 
each color-coded bar. Yellow bar = total number of genes expressed by ARPE-19 within the functional category/total number 
of genes expressed in all categories. The heights of the yellow bars may reflect the relative importance of a given function in 
ARPE-19 cells. Red bar = total number of genes expressed within the functional category/total number of genes represented 
on the HG-U133A GeneChip174 in all categories. Blue bar = total number of genes represented within the functional category/
total number of genes represented in all categories. Comparisons of the heights of the red versus blue bars in each category 
show considerable variation from the overall average of approximately 33% expressed. Based on a z-test analysis, categories 
that have statistically higher-than-predicted percentages expressed are noted by "+;" those with statistically lower-than-pre-
dicted percentages expressed are noted by "-." These differences indicate that the functional profile of genes expressed are not 
a simple reflection of the functional profile of genes represented on the chip. Abbreviations: Ca – calcium; BDNF – brain 
derived neurotrophic factor ; IGF – insulin growth factor; TRH – thyroid releasing hormone; GABA – gamma amino butyric 
acid; NADPH – nicotinamide adenine dinucleotide phosphate (reduced form); 5HT – 5 hydroxytryptamine; AMPA – alpha 
amino-3-hydroxy-5-methylisoxazole-4-proprionic acid; NMDA – n-methyl-d-aspartate.
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Functional categories of genes represented on the HG-U133A GeneChip174 and expressed by ARPE-19 cells. A 
total 130 functional categories are displayed on the abscissa. These are arranged alphabetically in groups under 15 large func-
tional subheadings indicated on the right and separated by dashed lines. The numbers of genes represented and expressed 
were converted into percentages indicated on the ordinate. The formulae used for calculating percentages were different for 
each color-coded bar. Yellow bar = total number of genes expressed by ARPE-19 within the functional category/total number 
of genes expressed in all categories. The heights of the yellow bars may reflect the relative importance of a given function in 
ARPE-19 cells. Red bar = total number of genes expressed within the functional category/total number of genes represented 
on the HG-U133A GeneChip174 in all categories. Blue bar = total number of genes represented within the functional category/
total number of genes represented in all categories. Comparisons of the heights of the red versus blue bars in each category 
show considerable variation from the overall average of approximately 33% expressed. Based on a z-test analysis, categories 
that have statistically higher-than-predicted percentages expressed are noted by "+;" those with statistically lower-than-pre-
dicted percentages expressed are noted by "-." These differences indicate that the functional profile of genes expressed are not 
a simple reflection of the functional profile of genes represented on the chip. Abbreviations: Ca – calcium; BDNF – brain 
derived neurotrophic factor ; IGF – insulin growth factor; TRH – thyroid releasing hormone; GABA – gamma amino butyric 
acid; NADPH – nicotinamide adenine dinucleotide phosphate (reduced form); 5HT – 5 hydroxytryptamine; AMPA – alpha 
amino-3-hydroxy-5-methylisoxazole-4-proprionic acid; NMDA – n-methyl-d-aspartate.
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further analysis. This choice of method was somewhat
arbitrary, but it had the advantage of being based strictly
on a statistical criterion and it should not introduce any
bias in the data since all probe sets, all genes, and all chips
were treated the same. The coefficient of variation data
was not used for any subsequent steps in the analysis. The
resulting database, free of redundant probes for any given
gene, was used for determining the number of genes
expressed within functional categories.
Functional categories were established for classification of
the majority of genes represented on the HG-U133A
GeneChip® , including those expressed by ARPE-19 cells.
(See Results for additional details.) HG-U133A Gene-
Chip® annotations were downloaded from Affymetrix.
Using FileMaker Pro 5.5 (FileMaker, Inc., Santa Clara,
CA), the following annotations were used to create a HG-
U133A GeneChip® Library: Probe Set ID, Title, Unigene
ID, Sequence Derived from, Sequence Description, Archi-
val Reference Group, Gene Symbol, GO Biological Proc-
ess, GO Molecular Function, Proteome Biochemical
Function, Proteome Cellular Role, Interpro ID and Classi-
fication, Ortholog-Homolog, and Pathways. Relational
databases were created by linking the HG-U133A Gene-
Chip® Library to the four data sets provided by the Affyme-
trix MAS 5.0 analysis. Search terms (i.e. keywords) were
used to extract the probe sets for each functional category.
The resulting classification scheme consisted of 130 func-
tional categories that could be grouped under 15 major
subheadings. Many of the genes could be classified in
more than one category. Genes were included in all the
categories in which they were classifiable. Additional liter-
ature searches were used to clarify ambiguities. In order to
determine whether the relative number of genes expressed
by ARPE-19 cells within a particular functional category
was significantly different from that predicted based on
numbers represented on the chip, we performed a z-test
Results
Numbers of genes expressed
The Affymetrix HG-U133A GeneChip® contains 22,283
probe sets representing 19,044 distinct genes, of which
6,438 genes were called as present in all four samples of
ARPE-19 cells with an alpha-1 value of 0.05. When
present calls were made with a less restrictive sensitivity
and specificity criterion (alpha-1 value was changed to
0.18), 8,671 genes were called present.
Establishment of functional categories
In order to establish a functional profile of genes, each of
the 19,044 distinct genes represented on the HG-U133A
GeneChip® was assigned a functional classification using
Affymetrix software search programs. By a process of trial
and error, these individual functional classifications were
organized into a limited number of function-related cate-
gories. Our goal was to establish a classification scheme
that would include as many genes as possible within a
"reasonable" number of functional categories. By this
process, we were able to select 130 functional categories
that accounted for 66.48% of the genes printed on the
HG-U133A GeneChip® and 70.94% of the genes
expressed by ARPE-19 cells. These categories are listed on
the abscissa of Figure 1 and 2, arranged under 15 major
functional subheadings. Most of the genes could be classi-
fied in more than one category. Genes were counted in
each functional category they were associated with, which
resulted in multiple listings of most genes. Roughly 33%
of the genes printed on the HG-U133A GeneChip® and
29% of the genes expressed by ARPE-19 cells could not be
classified in functional categories because the probes rep-
resented genes with unknown products or unknown func-
tions. In addition, certain functional categories
represented by very small numbers of genes were also
placed under the category of unclassified for practical rea-
sons.
A functional profile of gene expression
Rather than display the data as absolute numbers of genes
in each functional category, we chose to represent each
number as a percentage. Results are shown in Figure 1 and
2, using percentages calculated from the formulae listed
below.
The blue bars = the number of genes in a given category that
are represented on the HG-U133A GeneChip®/the total
number of genes represented on the HG-U133A Gene-
Chip® .
The red bars = the number of genes in a given category that
are expressed by ARPE-19/the total number of genes rep-
resented on the HG-U133A GeneChip® .
Results show that the functional profile of the genes
expressed by ARPE-19 was significantly different from the
functional profile of genes represented on the HG-U133A
GeneChip® . Overall, ARPE-19 expressed 33.8% of the rep-
resented genes. However, the percentage of genes
expressed in each functional category varied considerably
from that norm. Based on a z-test analysis, a total of 60 of
the 130 functional categories contained significantly
more or significantly less than the predicted number of
expressed genes (See Fig. 1 and 2).
An additional indication of the uniqueness of the ARPE-
19 functional gene profile can be seen in a comparison of
functional categories containing the largest percentages of
both represented and expressed genes. The ten categories
containing the largest numbers of genes are shown in
Table 1. These ten categories represent the same four basicPage 6 of 10
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duction, Metabolism, and Transport. In spite of this over-
all similarity, these two lists differ in several important
aspects. 1) Genes related to Metabolism and to Signal
Transduction-associated Metabolism were among the
most numerously expressed by ARPE-19, whereas these
genes were not among the most numerously represented
on the chip. The reverse was true for genes related to Tran-
scription Factors. 2) Of particular interest were several
cases in which ARPE-19 expressed approximately 50% or
more of the genes represented on the HG-U133A Gene-
Chip® . (See Fig. 1 and 2.) This occurred in functional cat-
egories that were large (i.e., Binding Protein, Hydrolase,
and Metabolism), as well as those that were small (i.e.,
Ribosomal Proteins and Protein Synthesis). Based on
these data, we conclude that the ARPE-19 Functional
Gene Expression Profile does reflect characteristics of the
ARPE-19 cell type and that it is not simply a reflection of
the functional groups of probe sets represented on the
HG-U133A GeneChip® .
We completed an additional calculation in which the
Functional Gene Expression Profile was expressed as a dif-
ferent type of percentage also shown in Fig. 1 and 2, using
the formula below:
Yellow bars = the number of genes within a given functional
category that are expressed by ARPE-19/Total number of genes
expressed.
This calculation is comparable to that used in constructing
a standard "pie chart," which has been routinely used by
other investigators to display the function of genes
expressed in a given cell type. Inclusion of 130 functional
categories used in our analysis adds considerably more
detail than could be contained on a normal pie chart for-
mat and thus cannot be presented as such. However, the
bar graph presentation does allow an expanded overview
of virtually all known genes within a reasonably simple
format. Results show that several functional categories of
genes account for a large portion of the total number of
genes expressed.
In the three largest functional categories (Binding Protein,
Cell Surface Receptors, and Receptors), the number of
genes expressed accounted for approximately 32% of the
total number of genes expressed. It must be kept in mind
that our classification scheme includes most genes in
more than one category and that there is likely to be con-
siderable overlap among these three categories. Thus, the
actual number of distinct genes in this functional group-
ing could be as low as 10%. Even so, this represents a
major functional class of genes expressed by ARPE-19.
In each of eight large categories, the number of genes
expressed accounted for approximately 5% of the total
number expressed. These latter categories represent genes
associated with cell signaling, transport, gene/protein
expression, and energy metabolism.
Effect of specificity/sensitivity parameters and substrate 
on gene classification
In order to determine the degree to which specificity and
sensitivity parameters influence the analysis and func-
tional categorization of the expressed genes, we altered
the alpha-1 value in the Microarray Suit 5.0 so that the
present calls were less specific but more sensitive, i.e., less
restrictive. When the alpha-1 value was changed from
0.05 to 0.075 only 570 additional genes were called
present, suggesting that our data were not overly influ-
enced by the sensitivity parameters originally selected. To
increase the number of present calls by approximately
Table 1: Functional Categories that Contain the Largest Percentages of Genes
Categories with ≥ 4% of genes represented on the chip Categories with ≥ 0.5% of genes expressed by ARPE
Functional Category Percentage* Functional Category Percentage 1 Percentage 2
Cell Sur face Receptors 9.6 Binding Proteins 4.2 12.3
Receptors 9.6 Cell Surface Receptors 2.3 6.8
Binding Proteins 9.6 Receptors 2.3 6.8
Kinase 5.4 Kinase 2.0 5.9
Signal transduction 5.4 Hydrolase 1.9 5.7
Transport (Metabolism) 5.1 Transport 1.9 5.6
Transport 5.1 Transport (Metabolism) 1.8 5.6
Transcription Factor 4.8 Signal transduction 1.7 4.9
Channels/Transport 
Proteins
4.2 Metabolism (signal 
transduction)
1.6 4.9
Hydrolase 4.3 Metabolism 1.6 4.7
* number of genes in a given category that are represented on the chip/ total number of genes represented on the chip
1 number of genes in a given category that are expressed by ARPE/ total number of genes represented on the chip
2 number of genes in a given functional category that are expressed by ARPE/ total number of genes expressedPage 7 of 10
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With this alpha-1 value, 8671 genes were called present in
all four samples.
To determine the degree to which our results were influ-
enced by variations in genes expressed by samples from
the four different culture substrates used, we compared
the number of genes expressed in all four samples with the
number of genes expressed in at least one of the samples.
Results show that 6438 genes were called present in all
samples and that 9749 genes were called present in at least
one sample. This suggests that substrate may have signifi-
cant effects on gene expression.
Discussion
Mapping of chromosomal positions and genomic organi-
zation of human genes has elucidated the chemical back-
ground of the genome [29], linking specific genes to
various human diseases. However, to understand the
pathophysiological mechanisms, it is prudent to resort to
functional genomics approaches [30,31]. Identifying the
genes expressed in a particular tissue and profiling their
function, as we have done in this study for a widely used
human retinal pigment epithelium cell line, lays the foun-
dations for such understanding.
An additional objective was to focus primarily on the
genes likely to be consistently expressed even under vary-
ing culture conditions, specifically when different sub-
strates were used. By including only substrate-
independent genes, the Profile may be more widely appli-
cable to labs using different culture conditions and sub-
strates. There is no standard substrate that is uniformly
accepted by ARPE-19 researchers; several are in common
usage (plastic, collagen, Matrigel, and fibronectin). Our
aim was to include genes that are expressed by the ARPE-
19 cells irrespective of the substrate. We cultured four
samples for microarray analysis, each on one of these four
substrates and then eliminated from our analysis any
genes that were not uniformly expressed by all four sam-
ples. Theoretically then, our analysis should be independ-
ent of specific substrate effects. It should be kept in mind,
however, that substrate-specific effects may play an
important role in RPE cells. In vivo, RPE cells grow in a
penta-lamellar structure called Bruch's membrane that is
thought to play an important role in the health and dis-
ease of RPE cells [1]. Changes in the Bruch's membrane
have been implicated in the pathogenesis of age-related
macular degeneration where RPE also plays an important
role. It has been shown that attachment of RPE cells to the
basement membrane is essential for its survival. All these
facts imply that the nature of basement membrane affects
the gene expression in RPE cells. These genes may not be
included in our database of 6,438 genes called present in
all four samples. For comparison, we calculated that 9,749
genes were expressed by at least one of the four samples.
This suggests that up to 3,311 genes could be substrate
specific. Additional experiments would be required in
order to confirm this suggestion and to the identity genes
that are specifically expressed in response to a given sub-
strate.
It is estimated that a typical mammalian cell expresses
about 10,000 to 20,000 mRNA species and in diseased
conditions between 0.2–10% of this may be differentially
expressed. Considering that approximately half of the
human genome is represented on the HG-U133A Gene-
Chip® , the detection of 6,438 genes falls within the
expected range. It is also estimated that approximately
10–20% of the entire genome is expressed in any cell type.
Our study gave a slightly higher value, with 33.8% of the
genes expressed in the ARPE-19 cells. This might reflect
the fact that we examined only genes that encode for pro-
teins whose identity and function are known. This group
includes many of the common housekeeping genes that
are expected to be expressed in most cells, and thus might
have a higher probability for detection in our analysis. The
group of unidentified genes not included in our analysis
may more likely include rare genes that would not be
expected to be as widely expressed.
The Functional Gene Expression Profile is not a strict
quantitative indicator of any given function because,
firstly, it takes into account only the expression of a gene
and not its level of expression. Secondly, individual genes
might have excitatory or inhibitory influence on a partic-
ular function. Lastly, the level of gene expression may not
be quantitatively related to the function. Other parame-
ters such as rate of translation, RNA turnover, post-transi-
tional modification and degradation rate of proteins can
all affect the degree to which a given gene and its protein
product contribute to the functional state of cells. Never-
theless, it is reasonable to assume that if a cell is actively
involved in a given function it will likely express many of
the genes involved in the corresponding functional path-
ways. Likewise, if the cell is not involved in a specific func-
tion it will express fewer of the genes related to those
functionally related pathways. Even though some genes
activate and others inhibit the function, a cell must main-
tain homeostasis and thus is likely to regulate any ongo-
ing activity – for example cell division – by balancing the
expression of excitatory and inhibitory factors. If this is
the case, all genes within appropriate cell division path-
ways would have a greater probability of being expressed
in an actively dividing cell than in one that is quiescent.
The actively dividing cell would have a higher level of
"gene chatter" within cell division pathways, which
should be reflected in a shift in the percentage of genes
expressed within that functional category. An additional
aim in developing a Functional Gene Expression ProfilePage 8 of 10
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major contribution that our work provides in this regard
is the development of a classification scheme of limited
size, which includes virtually all ARPE-19 expressed genes
whose functions are known. The classification scheme
was constructed using Affymetrix search terms (i.e., key
words) that appear in the HG-U133A GeneChip® annota-
tions, which provide a readily accessible, standard vocab-
ulary for the uniform classification of gene expression
data sets by other investigators. These GeneChip® annota-
tions are updated quarterly by Affymetrix. They can be eas-
ily downloaded and used to create or update GeneChip®
libraries and searchable relational databases.
The Profile is essentially an expanded pie chart, that con-
tains more information than can feasibly be presented in
a standard pie chart format. Nevertheless, it can be dis-
played in a reasonably sized bar graph with 130 data
points. By representing expression results as a percentage
of the total number of expressed genes, direct compari-
sons of expression information (albeit in compressed
form) can be made for virtually all functionally identified
genes across cell types, treatments, physiological states,
etc. Recently, somewhat similar approaches have been
used to make data mining SoftWear tools (EASE) that
allow comparisons of gene lists and search for gene cate-
gories over represented in a sample.
If the Function Gene Expression Profile is to be a useful as
a genetic blueprint for cell types or functional states, it
must be sensitive enough to reflect substantive differences
in gene expression that are unique for those specific cell
types or physiological sates. Experiments are underway to
prepare Profiles of appropriate data sets from other cell
types and to carry out comparative analyses. From these
comparisons, we will determine the degree to which Pro-
files differ, and more importantly, if these differences can
provide the basis for identification of genes and func-
tional pathways that are of particular relevance to the cell
or physiological state in question. Our current results do
show a significant difference in the profile of genes
expressed by ARPE-19 compared to the profile of the
genes represented on the HG-U133A GeneChip® . Thus,
we have one comparison that shows unique aspects of
ARPE-19 gene expression compared to all genes expressed
by all cells. Even in the absence of further comparative
data, the Profile provides a useful gene expression snap-
shot of a confluent monolayer of ARPE-19 cells. The high-
est percentages of genes expressed were in categories that
could be related to specialized RPE functions (receptors
and binding proteins) and those that may be related to
housekeeping genes (energy metabolism, transport, and
gene/protein expression). The quiescent state of the cul-
ture is consistent with low percentages of genes expressed
in functional categories that include cell division, cell
growth, and cell structure/mobility.
Conclusion
We present a system of profiling the expressed genes based
on their functions. The Profile can be compared with
equivalent microarray data from other appropriate sam-
ples in order to highlight cell-specific attributes or treat-
ment-induced changes in gene expression. The usefulness
of these analyses is based on the assumption that the
numbers of genes expressed within a functional category
provide an indicator of the overall level of activity within
that particular functional pathway.
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